BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6127024)

  • 1. Unusual complications of antipsychotic drugs.
    Diamond JM; Santos AB
    Am Fam Physician; 1982 Oct; 26(4):153-7. PubMed ID: 6127024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuroleptic malignant syndrome.
    Smego RA; Durack DT
    Arch Intern Med; 1982 Jun; 142(6):1183-5. PubMed ID: 6124221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ocular pigmentation and phenothiazine derivatives].
    Calluaud JL; Di Battista JC; Douenne JL; Lagoutte F
    Bull Soc Ophtalmol Fr; 1977; 77(7-8):661-4. PubMed ID: 26474
    [No Abstract]   [Full Text] [Related]  

  • 4. [Oculotoxic and dermatotoxic side effects of phenothiazines].
    Garenfeld W; Wilting I
    Tijdschr Psychiatr; 2007; 49(4):251-5. PubMed ID: 17436211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular complications of phenothiazines.
    Mathalone MB
    Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613
    [No Abstract]   [Full Text] [Related]  

  • 6. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs affecting the eye.
    Taylor F
    Aust Fam Physician; 1985 Aug; 14(8):744-5. PubMed ID: 2864912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome complicated by disseminated intravascular coagulation.
    Eles GR; Songer JE; DiPette DJ
    Arch Intern Med; 1984 Jun; 144(6):1296-7. PubMed ID: 6732389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Corneal and lens deposits due to treatment by phenothiazine type neuroleptics].
    Pouget R; Blayac JP; Largey B; Alric R; Castelnau D; Boulet J
    Ann Med Psychol (Paris); 1976 Mar; 1(3):403-7. PubMed ID: 7987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Persistence of bilateral pigmentary deposits in stromal cornea in a woman after a brief treatment with antidepressants].
    Panzitt M; Simon M; Weger M
    Klin Monbl Augenheilkd; 2001 Apr; 218(4):273-5. PubMed ID: 11392274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract]   [Full Text] [Related]  

  • 12. The neuroleptic malignant syndrome.
    Schrader G; Wong C; Russell R; Goldney RD
    Med J Aust; 1981 Oct; 2(9):494. PubMed ID: 6119606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complications of current coronarodilatator agents].
    Huriez C; François P; Bergoend H; Thomas P
    Lille Med; 1972 May; 17(5):749-54. PubMed ID: 4262479
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ocular lesions caused by phenothiazines].
    Delorme R; Ballereau L; Baïkoff G; Quéré MA
    Bull Soc Ophtalmol Fr; 1973 Apr; 73(4):591-3. PubMed ID: 4152702
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug-induced eye lesions in the aged].
    Slezak H
    Aktuelle Gerontol; 1983 Sep; 13(5):187-90. PubMed ID: 6139035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant neuroleptic syndrome].
    Kaartinen P; Väisänen E; Reunanen M
    Duodecim; 1982; 98(12):944-9. PubMed ID: 6127200
    [No Abstract]   [Full Text] [Related]  

  • 17. [The "malignant" neuroleptic syndrome].
    Snoek JW; van den Hoofdakker RH; Haaxma R
    Ned Tijdschr Geneeskd; 1982 Jan; 126(2):74-6. PubMed ID: 6119630
    [No Abstract]   [Full Text] [Related]  

  • 18. [Malignant neuroleptic syndrome].
    Bjørndal N; Remvig J; Gottlieb P
    Ugeskr Laeger; 1983 Feb; 145(8):570-3. PubMed ID: 6134367
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous and ocular changes associated with the use of chlorpromazine.
    Wolf ME; Richer S; Berk MA; Mosnaim AD
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.